Business Highlights

Merck posts strong 2Q numbers, while building for long term ... Meanwhile, it's trying to offset falling sales or slowing growth due to increased generic and brand-name competition for best sellers including immune disorder drug Remicade, cholesterol ...
http://www.dailyherald.com/article/20160729/business/307299812/